We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$438M
AUM Growth
+$79M
Cap. Flow
+$165M
Cap. Flow %
37.75%
Top 10 Hldgs %
55.67%
Holding
153
New
56
Increased
27
Reduced
23
Closed
42

Top Buys

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$111M
2
NVS icon
Novartis
NVS
+$41.1M
3
RDHL
Redhill Biopharma
RDHL
+$23M
4
JNJ icon
Johnson & Johnson
JNJ
+$20M
5
LLY icon
Eli Lilly
LLY
+$16.7M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$9.18M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$7.75M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$7.1M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.09M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 73.63%
2 Consumer Discretionary 3%
3 Technology 2.66%
4 Industrials 1.84%
5 Consumer Staples 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTE icon
101
Caesarstone
CSTE
$72.3M
$426K 0.1%
+7,830
New +$413K
FRTX
102
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$387K 0.09%
+95
New +$424K
INSM icon
103
CALL
Insmed
INSM
$21.4B
$355K 0.08%
+1,000
New +$19K
IPXL
104
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$335K 0.08%
+1,000
New +$25K
AUXL
105
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$332K 0.08%
+935
New +$24.8K
CORT icon
106
CALL
Corcept Therapeutics
CORT
$12.4B
$124K 0.03%
+1,206
New +$4.21K
PFE icon
107
CALL
Pfizer
PFE
$143B
$82K 0.02%
2,108
-685,205
-100% -$20.4M
CYTK icon
108
CALL
Cytokinetics
CYTK
$10.5B
$16K ﹤0.01%
+131
New +$1.19K
AAPL icon
109
Apple
AAPL
$4.54T
– –
-154,560
Closed -$3.1M
ACAD icon
110
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-60,000
Closed -$1.5M
ACHV icon
111
Achieve Life Sciences
ACHV
$659M
– –
-34
Closed -$618K
ARWR icon
112
Arrowhead Research
ARWR
$11.9B
– –
-20,000
Closed -$217K
CMG icon
113
Chipotle Mexican Grill
CMG
$47.2B
– –
-122,500
Closed -$1.3M
CPRT icon
114
Copart
CPRT
$27B
– –
-457,600
Closed -$2.1M
ENTA icon
115
Enanta Pharmaceuticals
ENTA
$366M
– –
-25,292
Closed -$690K
FL
116
DELISTED
Foot Locker
FL
– –
-55,119
Closed -$2.28M
GERN icon
117
Geron
GERN
$828M
– –
-105,800
Closed -$474K
GILD icon
118
PUT
Gilead Sciences
GILD
$162B
– –
-120,000
Closed -$9.02M
GYRE icon
119
Gyre Therapeutics
GYRE
$641M
– –
-381
Closed -$1.25M
INVA icon
120
Innoviva
INVA
$1.55B
– –
-35,369
Closed -$1.02M
IONS icon
121
Ionis Pharmaceuticals
IONS
$8.6B
– –
-30,000
Closed -$1.2M
ITB icon
122
iShares US Home Construction ETF
ITB
$2.26B
– –
-102,000
Closed -$2.53M
IWM icon
123
iShares Russell 2000 ETF
IWM
$79.8B
– –
-67,209
Closed -$7.75M
JNJ icon
124
CALL
Johnson & Johnson
JNJ
$618B
– –
-350,000
Closed -$32.1M
MDGL icon
125
CALL
Madrigal Pharmaceuticals
MDGL
$10.8B
– –
-2,857
Closed -$524K
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sphera Funds Management held 153 positions worth $438M, up 22% from $359M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sphera Funds Management deployed $165M of net new capital in Q1 2014, opening 56 new positions and adding to 27 existing holdings. Its largest new stake was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $4.09M trimmed.

  • Sphera Funds Management's largest Q1 2014 buy was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.
  • Sphera Funds Management added most to Novartis in Q1 2014, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $4.09M.
  • Sphera Funds Management fully exited Shire pic in Q1 2014, selling an estimated $9.18M.
  • Sphera Funds Management's ten largest holdings make up 56% of its $438M portfolio in Q1 2014.
  • Sphera Funds Management opened 56 new positions and closed 42 in Q1 2014.
  • Sphera Funds Management's portfolio value rose 22% quarter-over-quarter to $438M.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.